Inclusion Criteria:
  -  Adenocarcinoma of the prostate
  -  Performance Status < 2
  -  Clinical stages (not radiographic stage) T1c - T2a, Nx or N0, Mx or M0
  -  Gleason 6-7 cancer
  -  Prostate volume < 60 cc (if MRI and TRUS have conflicting values, then MRI value will be utilized)
  -  International Prostate symptom score (IPSS) 20 or less
  -  Ability to undergo DCF-Pyl PSMA PET as part of pretreatment staging
  -  Signed study-specific consent form prior to registration
Exclusion Criteria:
  -  Prior history of pelvic radiation therapy
  -  Major medical or psychiatric illness which, in the investigator's opinion, would prevent completion of treatment and would interfere with follow up.
  -  Implanted device or apparatus which obstruct visibility of the implanted sources on fluoroscopy
  -  Metallic implants, claustrophobia not amenable to medication, or known contraindications to undergoing MR scanning
  -  History of other malignancy diagnosed within the past 3 years